Trials / Completed
CompletedNCT06551740
Phase 1 Study in Diabetes Mellitus(Fed)
An Open-label, Randomized, Fed, Single-dose, 2-sequence, 2-period, Crossover Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of HUC2-344 and Co-administration of HUC2-344-R1 and HUC2-344-R2 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Huons Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
An open-label, randomized, Fed, single-dose, 2-sequence, 2-period, crossover phase 1 study in healthy volunteers.
Detailed description
An Open-label, Randomized, Fed, Single-dose, 2-sequence, 2-period, Crossover Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of HUC2-344 and Co-administration of HUC2-344-R1 and HUC2-344-R2 in Healthy Volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HUC2-344 | per oral |
| DRUG | HUC2-344-R1, HUC2-344-R2 | per oral |
Timeline
- Start date
- 2024-04-15
- Primary completion
- 2024-06-10
- Completion
- 2024-06-10
- First posted
- 2024-08-13
- Last updated
- 2024-08-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06551740. Inclusion in this directory is not an endorsement.